Association between plasma concentrations of plasminogen activator inhibitor-1 and survival in patients with colorectal cancer

British Medical Journal

Volumn 316, Issue 7134, 1998, Pages 829-830

  Nielsen, Hans Jørgen ^a   Pappot, Helle ^b   Christensen, Ib Jarle ^b   Brünner, Nils ^b   Thorlacius Ussing, Ole ^c   Moesgaard, Flemming ^a   Danø, Keld ^b   Grøndahl Hansen, Jan ^b  

^a HVIDOVRE HOSPITAL   (Denmark)

^b FINSEN LABORATORY   (Denmark)

^c AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1;

ARTICLE; BLOOD LEVEL; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL;

EID: 0032515761     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.316.7134.829     Document Type: Article

References (5)

1. Danø K, Andreasen PA, Grondahl-Hansen J, Kristensen P, Nielsen LS, Skriver L. Plasminogen activators, tissue degradation and cancer. Acta Cancer Res 1985;41:139-266.
2. Andreasen PA, Georg B, Lund LR, Riccio A, Stacey SN. Plasminogen activator inhibitors: hormonally regulated serpins. Mol Cell Endocrinol 1990;68:1-19.
3. Grøndahl-Hansen J, Christensen IJ, Rosenquist C, Brünner N, Mouridsen HT, Danø K, et al. High level of urokinase-type plasminogen activator and its inhibitor PAI-I in cytosolic extracts of breast carcinomas are associated with poor prognosis. Cancer Res 1993;53:2513-21.
4. Casslen B, Bossmar T, Lecander I, Åstedt B. Plasminogen activators and plasminogen activator inhibitors in blood and tumour fluids of patients with ovarian cancer. Eur J Cancer 1994;30A:1302-9.
5. Meijer P, Pollet DE, Wauters J, Kluft C. Specificity of antigen assays of plasminogen activator inhibitor in plasma: Innotest plasminogen activator inhibitor-I immunoassay evaluated. Clin Chem 1991;10:110-5.